108 related articles for article (PubMed ID: 9491134)
1. Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma.
Tsuda H; Sakamaki C; Tsugane S; Fukutomi T; Hirohashi S
Jpn J Clin Oncol; 1998 Jan; 28(1):5-11. PubMed ID: 9491134
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases.
Tsuda H; Sakamaki C; Tsugane S; Fukutomi T; Hirohashi S
Breast Cancer Res Treat; 1998 Mar; 48(1):21-32. PubMed ID: 9541186
[TBL] [Abstract][Full Text] [Related]
3. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
Tsuda H; Fukutomi T; Hirohashi S
Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene.
Tsuda H; Tsugane S; Fukutomi T; Nanasawa T; Yamamoto H; Hirohashi S
Jpn J Clin Oncol; 1992 Aug; 22(4):244-9. PubMed ID: 1359174
[TBL] [Abstract][Full Text] [Related]
5. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
6. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
7. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.
Zhang GJ; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
Jpn J Clin Oncol; 1997 Dec; 27(6):371-7. PubMed ID: 9437997
[TBL] [Abstract][Full Text] [Related]
9. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
Cuny M; Kramar A; Courjal F; Johannsdottir V; Iacopetta B; Fontaine H; Grenier J; Culine S; Theillet C
Cancer Res; 2000 Feb; 60(4):1077-83. PubMed ID: 10706127
[TBL] [Abstract][Full Text] [Related]
10. int-2 oncogene amplification and prognosis in node-negative breast carcinoma.
Fioravanti L; Cappelletti V; Coradini D; Miodini P; Borsani G; Daidone MG; Di Fronzo G
Int J Cancer; 1997 Dec; 74(6):620-4. PubMed ID: 9421359
[TBL] [Abstract][Full Text] [Related]
11. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
12. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.
Tsuda H
Breast Cancer; 2009; 16(3):186-201. PubMed ID: 19472036
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological implications of gene alterations in breast cancer].
Tsuda H
Rinsho Byori; 1993 Oct; 41(10):1092-8. PubMed ID: 7902882
[TBL] [Abstract][Full Text] [Related]
14. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
15. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Ottestad L; Andersen TI; Nesland JM; Skrede M; Tveit KM; Nustad K; Børresen AL
Acta Oncol; 1993; 32(3):289-94. PubMed ID: 8100712
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
Tsuda H; Iwaya K; Fukutomi T; Hirohashi S
Jpn J Cancer Res; 1993 Apr; 84(4):394-401. PubMed ID: 8099903
[TBL] [Abstract][Full Text] [Related]
17. c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse.
Roux-Dosseto M; Romain S; Dussault N; Desideri C; Piana L; Bonnier P; Tubiana N; Martin PM
Eur J Cancer; 1992; 28A(10):1600-4. PubMed ID: 1356387
[TBL] [Abstract][Full Text] [Related]
18. The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer.
Bull SB; Ozcelik H; Pinnaduwage D; Blackstein ME; Sutherland DA; Pritchard KI; Tzontcheva AT; Sidlofsky S; Hanna WM; Qizilbash AH; Tweeddale ME; Fine S; McCready DR; Andrulis IL
J Clin Oncol; 2004 Jan; 22(1):86-96. PubMed ID: 14701769
[TBL] [Abstract][Full Text] [Related]
19. INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes.
Pauley RJ; Gimotty PA; Paine TJ; Dawson PJ; Wolman SR
Breast Cancer Res Treat; 1996; 37(1):65-76. PubMed ID: 8750529
[TBL] [Abstract][Full Text] [Related]
20. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]